Target intelligence / Profile preview

Mitochondrial membrane components

Molecular classification
Other
01

Overview

Mitochondrial membrane components encompass the structural and functional elements of the outer (OMM) and inner mitochondrial membranes (IMM). The OMM regulates the entry of metabolites and serves as a scaffold for BCL-2 family proteins that control programmed cell death (apoptosis) (Source: Wikipedia, NCBI). The IMM contains the protein complexes of the electron transport chain (ETC) and ATP synthase, which are responsible for the majority of cellular ATP production through oxidative phosphorylation (Source: StatPearls). Dysregulation of these components is linked to a wide array of conditions, including cancer, neurodegenerative disorders like Parkinson's disease, and primary mitochondrial myopathies (Source: PubMed). Pharmacological agents target these membranes through various mechanisms, such as inhibiting respiratory complexes (e.g., metformin targeting Complex I), modulating the mitochondrial permeability transition pore (mPTP), or stabilizing mitochondrial-specific lipids like cardiolipin (Source: PubChem, Stealth BioTherapeutics). Due to their central role in metabolism, targeting these components requires careful management of potential systemic toxicity and metabolic side effects (Source: FDA).

Other names
Mitochondrial membraneMitochondrial envelopeOuter mitochondrial membraneInner mitochondrial membraneMitochondrial cristae
02

Mechanism of action

Drugs targeting mitochondrial membrane components act by inhibiting the electron transport chain complexes, antagonizing anti-apoptotic BCL-2 family proteins, stabilizing cardiolipin to improve cristae structure, or preventing the opening of the mitochondrial permeability transition pore.

03

Biological functions

ATP productionApoptosisCalcium homeostasisMetabolite transportReactive oxygen species (ROS) generationHeme biosynthesis
04

Disease associations

CancerNeurodegenerative diseaseMitochondrial myopathyCardiovascular diseaseType 2 diabetes mellitusLeigh syndrome
05

Safety considerations

Mitochondrial toxicityLactic acidosisSystemic metabolic disruptionInduction of unintended apoptosis in healthy tissuesCardiotoxicity
06

Interacting drugs

Metformin

7 more in the full profile.

07

Biomarkers

Mitochondrial membrane potential (ΔΨm)Cytochrome c releaseLactate-to-pyruvate ratioCirculating mitochondrial DNA (mtDNA)Oxygen consumption rate (OCR)

Beyond the preview

Go deeper on Mitochondrial membrane components.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mitochondrial membrane components.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call